DAE HWA Pharmaceutical Co. Ltd (067080) — Net Asset Quality Index
DAE HWA Pharmaceutical Co. Ltd (067080) has a Net Asset Quality Index of 37.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩210.86 Billion minus total liabilities of ₩131.72 Billion yields net assets of ₩79.14 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check DAE HWA Pharmaceutical Co. Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
DAE HWA Pharmaceutical Co. Ltd Net Asset Quality Index Over Time (2011–2025)
This chart shows how DAE HWA Pharmaceutical Co. Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the index stands at 37.5%, representing net assets of ₩79.14 Billion against total assets of ₩210.86 Billion KRW. See DAE HWA Pharmaceutical Co. Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for DAE HWA Pharmaceutical Co. Ltd (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for DAE HWA Pharmaceutical Co. Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see DAE HWA Pharmaceutical Co. Ltd (067080) market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 37.5% | ₩79.14 Billion | ₩210.86 Billion | ₩131.72 Billion | ▲ +2.6 pp |
| 2024 | 35.0% | ₩72.00 Billion | ₩205.88 Billion | ₩133.89 Billion | ▲ +1.6 pp |
| 2023 | 33.4% | ₩73.23 Billion | ₩219.16 Billion | ₩145.93 Billion | ▼ -5.8 pp |
| 2022 | 39.2% | ₩77.99 Billion | ₩199.06 Billion | ₩121.06 Billion | ▼ -5.7 pp |
| 2021 | 44.9% | ₩79.67 Billion | ₩177.38 Billion | ₩97.70 Billion | ▼ -1.9 pp |
| 2020 | 46.8% | ₩81.98 Billion | ₩175.05 Billion | ₩93.07 Billion | ▼ -0.9 pp |
| 2019 | 47.8% | ₩79.35 Billion | ₩166.15 Billion | ₩86.80 Billion | ▲ +0.3 pp |
| 2018 | 47.4% | ₩76.88 Billion | ₩162.06 Billion | ₩85.17 Billion | ▲ +1.1 pp |
| 2017 | 46.4% | ₩76.75 Billion | ₩165.47 Billion | ₩88.72 Billion | ▲ +3.4 pp |
| 2016 | 43.0% | ₩66.15 Billion | ₩153.80 Billion | ₩87.65 Billion | ▼ -6.0 pp |
| 2015 | 49.0% | ₩61.06 Billion | ₩124.61 Billion | ₩63.55 Billion | ▲ +1.8 pp |
| 2014 | 47.2% | ₩58.51 Billion | ₩124.07 Billion | ₩65.57 Billion | ▼ -3.7 pp |
| 2013 | 50.9% | ₩62.03 Billion | ₩121.87 Billion | ₩59.84 Billion | ▲ +3.7 pp |
| 2012 | 47.2% | ₩61.39 Billion | ₩130.19 Billion | ₩68.80 Billion | ▲ +5.1 pp |
| 2011 | 42.0% | ₩56.99 Billion | ₩135.58 Billion | ₩78.60 Billion | — |